Research Keyword: CYP51A

Exposure to Tebuconazole Drives Cross-Resistance to Clinical Triazoles in Aspergillus fumigatus

When farmers use antifungal pesticides called triazoles to protect crops, the fungi can develop resistance to these chemicals. This study found that when the fungus Aspergillus fumigatus is exposed to the agricultural triazole tebuconazole, it can become resistant not only to that pesticide but also to clinical triazole drugs used to treat human fungal infections. The resistant fungi maintain this resistance even when the pesticide is removed, suggesting that environmental pesticide use may threaten the effectiveness of medical antifungal treatments.

Read More »

RttA, a Zn2-Cys6 transcription factor in Aspergillus fumigatus, contributes to azole resistance

Researchers discovered that a protein called RttA helps a common fungus called Aspergillus fumigatus resist azole medicines, which are used to treat serious fungal infections. By studying how this protein works and which genes it controls, scientists found that RttA could be a new target for developing better antifungal treatments. The findings are important because azole-resistant fungal infections are becoming more common worldwide and harder to treat.

Read More »

RttA, a Zn2-Cys6 transcription factor in Aspergillus fumigatus, contributes to azole resistance

Researchers discovered that a fungal protein called RttA plays a key role in helping Aspergillus fumigatus resist azole antifungal drugs. By studying mutant strains, they found that RttA acts as a master switch controlling genes that reduce the effectiveness of antifungal medications. This finding is important because it could help develop new strategies to treat fungal infections that are becoming resistant to current medications.

Read More »

The transcription factor RttA contributes to sterol regulation and azole resistance in Aspergillus fumigatus

Researchers corrected the mislabeled rttA gene in the dangerous fungus Aspergillus fumigatus and discovered it acts as a master control switch for sterol production and antifungal drug resistance. When this gene is active, it helps fungi survive azole medications by boosting production of ergosterol, a critical component of fungal cell membranes. This discovery reveals how fungi develop resistance to our frontline antifungal treatments and suggests new ways to combat these life-threatening infections.

Read More »
Scroll to Top